Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Tilos Therapeutics logo — Developing innovative antibody therapeutics to target crucia...

Tilos Therapeutics

Developing innovative antibody therapeutics to target crucial immunological pathways with a focus on regulatory T cells and effector cell regulation.

Founded 2016 Series Unknown Total: $3.80M Biotechnology, Health and Wellness +1

General Information

Company Name Tilos Therapeutics
Founded Year 2016
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Tilos Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Tilos Therapeutics

Tilos Therapeutics is a biotechnology and pharmaceutical startup that focuses on developing innovative antibody therapeutics targeting crucial immunological pathways, with a specific emphasis on regulatory T cells and effector cell regulation. Founded in 2016 and headquartered in Cambridge, Massachusetts, the company's initial research is centered around antibodies specific to Latency Associated Peptide of TGF beta. In September 2017, Tilos Therapeutics secured a $3.05M Venture Round investment, with ShangPharma being the lead investor in this round.

Taxonomy: biopharmaceuticals, antibody therapeutics, immunological pathways, regulatory T cells, effector cell regulation, Latency Associated Peptide, TGF beta, biotech startup, Cambridge, Massachusetts

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
21 Sep 2017
Seed Round •••••• - 30 Aug 2016

Tilos Therapeutics Alternatives & Competitors

Tilos Therapeutics vs
The Institute for Learning-enabled Optimization at Scale (TILOS)
The Institute for Learning-enabled Optimization at Scale (TILOS) United States

Pioneering learning-enabled optimizations that transform chip design, robotics, and networks.

Grant
1 employees
Cyber Security
Tilos Therapeutics vs
Centro Médico Los Tilos
Centro Médico Los Tilos Spain

Velamos por el cuidado médico, el bienestar y la atención personalizada de los pacientes que confían...

24 employees
Tilos Therapeutics vs
Stemgenics, Inc
Stemgenics, Inc

Stemgenics has developed a breakthrough technology that converts mature cells (skin cells) into pers...

Series Unknown
2 employees
Biotechnology, Health and Wellness

FAQ About Tilos Therapeutics

Developing innovative antibody therapeutics to target crucial immunological pathways with a focus on regulatory T cells and effector cell regulation.
Tilos Therapeutics was founded in 2016.
Tilos Therapeutics operates in the following industries: Biotechnology, Health and Wellness, Pharmaceutical.
Tilos Therapeutics has completed 2 funding rounds, raising a total of $3.80M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Tilos Therapeutics include The Institute for Learning-enabled Optimization at Scale (TILOS), Centro Médico Los Tilos, Stemgenics, Inc, AlphaMed Press, Acorn Biolabs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tilos Therapeutics and The Institute for Learning-enabled Optimization at Scale (TILOS) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Tilos Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy